BetterLife Pharma BETRF
OTC BETRF
$0.18 +0.03 (+20.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

BetterLife Pharma (BETRF) Long-Term Debt Repayments (2018 - 2026)

Updated

BetterLife Pharma (BETRF) recorded Long-Term Debt Repayments of -$2,338 in fiscal Q2 2027 (quarter ended Jul 31, 2026).

Analysis

BetterLife Pharma (BETRF) Long-Term Debt Repayments (2018 - 2026) Analysis & Trends

On a TTM basis, BetterLife Pharma's Long-Term Debt Repayments came in at -$154,066 as of Jul 31, 2026; for FY2026 (ended Jan 31, 2026), it was -$3,540.

  • Across earlier fiscal years, Long-Term Debt Repayments came in at $95,810 in FY2022.
  • The fiscal Q2 2027 figure is the highest quarterly Long-Term Debt Repayments since fiscal Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 1.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 2.00 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 2.46 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 17.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 BetterLife Pharma 26.20 Mn 25.46 Mn - -2,338.08
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 -2,338.08
Apr 30, 2026 -2,370.17
Jan 31, 2022 292,330.20
Jan 31, 2020 36,479.78
Jul 31, 2019 546,584.86
Apr 30, 2019 -563,498.07
Apr 30, 2018 12,510.41
API Access

BetterLife Pharma Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=BETRF&period=max&api_key=YOUR_API_KEY